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Background: Disorders within the schizophrenia spectrum genetically overlap with bipolar disorder, yet ques-
tions remain about shared biological phenotypes. Investigation of brain structure in disease has been enhanced
by developments in shape analysis methods that can identify subtle regional surface deformations. Our study
aimed to identify brain structure surface deformations that were common across related psychiatric disorders,
and characterize differences.
Methods:Using the automated FreeSurfer-initiated Large Deformation DiffeomorphicMetricMapping, we exam-
ined volumes and shapes of seven brain structures: hippocampus, amygdala, caudate, nucleus accumbens, puta-
men, globus pallidus and thalamus. We compared ﬁndings in controls (CON; n = 40), and those with
schizophrenia (SCZ; n = 52), schizotypal personality disorder (STP; n = 12), psychotic bipolar disorder (P-BP;
n = 49) and nonpsychotic bipolar disorder (N-BP; n = 24), aged 15–35. Relationships between morphometric
measures and positive, disorganized and negative symptoms were also investigated.
Results: Inward deformation was present in the posterior thalamus in SCZ, P-BP and N-BP; and in the subiculum
of the hippocampus in SCZ and STP. Most brain structures however showed unique shape deformations across
groups. Correcting for intracranial size resulted in volumetric group differences for caudate (p b 0.001), putamen
(p b 0.01) and globus pallidus (p b 0.001). Shape analysis showed dispersed patterns of expansion on the basal
ganglia in SCZ. Signiﬁcant clinical relationships with hippocampal, amygdalar and thalamic volumes were ob-
served.
Conclusions: Few similarities in surface deformation patterns were seen across groups, which may reﬂect differ-
ing neuropathologies. Posterior thalamic contraction in SCZ and BP suggest common genetic or environmental
antecedents. Surface deformities in SCZ basal ganglia may have been due to antipsychotic drug effects.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords:
Schizophrenia
Bipolar
Schizoid personality
Shape
Hippocampus
Amygdala
Basal ganglia
Thalamus
1. Introduction
The term schizophrenia spectrumdisorder has been used to describe a
range of psychiatric conditions, including schizophrenia (SCZ), that
share some genetic risk variants and clinical manifestations (Mamah
and Barch, 2011). Among these, schizotypal personality disorder (STP)
is the most commonly included in studies of the spectrum. This condi-
tion is typically not associated with ﬂorid psychotic symptoms of
schizophrenia (such as hallucinations and bizarre delusions), but rather
cognitive or perceptual distortions and eccentricities in everyday be-
havior. Bipolar disorder (BP) is not traditionally included among the
schizophrenia spectrum disorders, despite the fact that genetic and
familial overlap is presentwith SCZ (Cardno andOwen, 2014). Psychotic
bipolar disorder (P-BP) has clinical similarities with SCZ and also has
been reported to more closely overlap genetically with SCZ compared
to nonpsychotic bipolar disorder (N-BP). Notwithstanding the relation-
ship across these disorders, few studies have compared their brain
structure (Mamah et al., 2009). Such studieswould provide information
on the extent of similarities between disorders, and help clarify the phe-
notypic manifestations of speciﬁc genetic proﬁles.
Volumetric analyses of structural brain imaging data have been a
mainstay of brain structure investigations in psychiatry. In recent
years, developments in shape analysis methodology have led to struc-
turalmeasures that can supplement data derived from volumetric anal-
ysis. In studies of disease, investigation of the three-dimensional
surfaces of brain subcortical structures have been shown to identify
group abnormalities where the volumetric analysis did not, indicating
that subtle surface abnormalities are more sensitive to shape than size
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(Mamah et al., 2009). Since shape analysis enables the uncovering of lo-
calized deformations on the surface of a brain structure, it may more
precisely identify impaired pathways within the brain. This is particu-
larly important in the study of brain structureswith explicit regional dif-
ferentiation in function, such as the thalamus (Sherman and Guillery,
2013) or striatum (Verstynen et al., 2012; Draganski et al., 2008;
Lehericy et al., 2004). Previous shape analyses have been conducted in
psychiatric patients, including those with SCZ,(Mamah et al., 2009;
Csernansky et al., 2004; Smith et al., 2011; Danivas et al., 2013; Kang
et al., 2008; Csernansky et al., 2002; Mamah et al., 2012; Johnson
et al., 2013; Qiu et al., 2010; Zierhut et al., 2013; Styner et al., 2004;
Shenton et al., 2002; Mamah et al., 2008; Mamah et al., 2007;
Ballmaier et al., 2008) BP(Qiu et al., 2013; Hwang et al., 2006; Womer
et al., 2014; Ong et al., 2012; Liberg et al., 2014; Liberg et al., 2015) or
STP,(Levitt et al., 2009; Levitt et al., 2004) often with varying results.
However, studies are often conducted using differing recruitment
criteria, scanners, imaging protocols and analyses methodology, which
can signiﬁcantly inﬂuence results. Thus, investigating various diagnostic
patient groups in a single study,with identical protocol, is therefore nec-
essary to obtain valid comparisons. Our shape analysis represents the
most extensive investigation of its kind to our knowledge, comparing
multiple subcortical brain structures across several diagnostic groups.
We used an automated shape analysismethodology involving Large De-
formation Diffeomorphic Metric Mapping (LDDMM) that has been val-
idated and previous applied in the evaluation of disease (Khan et al.,
2008; Ceyhan et al., 2011; Qiu et al., 2009).
In the current study, we investigated the volumes and shapes of
seven subcortical structures simultaneously (i.e. the hippocampus,
amygdala, caudate, putamen, globus pallidus, nucleus accumbens, and
thalamus). We compared ﬁndings in healthy controls to those of indi-
vidualswith SCZ, psychotic (P-BP) and nonpsychotic (N-BP) bipolar dis-
order, and STP, obtained using the same MRI scanner, imaging protocol
and analysis methodology. We hypothesize that overlapping structural
abnormalitieswill exist across these groups, with SCZmost affected. Ab-
normalities are expected to be largely trend toward shrinkage, and be
best captured by shape analysis. Due to a probable past history of typical
antipsychotic drug use, we hypothesize that the basal ganglia in SCZwill
be enlarged.
2. Materials and methods
2.1. Participants
The study was approved by the Institutional Review Board of
WashingtonUniversity. Participant groups included: 1) healthy controls
(CON;n=40); 2) bipolar disorder (BP; n=73); 3) schizophrenia (SCZ;
n = 52); and 4) schizotypal personality disorder (STP; n = 12). Partic-
ipants' ages ranged between 15 and 35 yrs. Participants were recruited
through targeted advertisements in local psychiatric clinics, hospitals,
and newspapers and through the Washington University volunteers
for health recruitment system. All participants gave written informed
consent for participation. SCZ and BP participants were all outpatients,
and clinically stable for at least two weeks. They were diagnosed on
the basis of a consensus between a research psychiatrist and a trained
research assistant who used the Structured Clinical Interview for
DSM-IV Axis I Disorders (SCID-I). The Structured Clinical Interview for
DSM-IVAxis II Disorders (SCID-II)was used to ascertain groupdiagnosis
in STP participants. CON subjects were required to have no lifetime his-
tory of Axis I psychotic or mood disorders. Participants were excluded if
they: (a)met DSM-IV criteria for substance dependence or severe/mod-
erate abuse during the prior 6 months; (b) had a clinically unstable or
severe general medical disorder; or (c) had a history of head injury
with documented neurological sequelae or loss of consciousness. BP
participants were subdivided into psychotic bipolar disorder (P-BP;
N = 49) and nonpsychotic bipolar disorder (N-BP; N = 24) based on
the presence or absence of a lifetime history of hallucinations and/or
non-grandiose delusions using the SCID-I. Demographic data are
shown in Table 1.
2.2. Clinical assessment
Psychopathology was assessed by trained Masters level research as-
sistants using the Scale for the Assessment of Negative Symptoms
(SANS) and the Scale for the Assessment of Positive Symptoms (SAPS)
(Andreasen et al., 1995). Speciﬁc subscale scores were summed to de-
rive measures of positive symptoms (i.e. hallucination and delusion
subscales), disorganization (i.e. formal thought disorder, bizarre behav-
ior and attention subscales), and negative symptoms (i.e. ﬂat affect,
alogia, anhedonia and amotivation subscales).
2.3. Image acquisition and surface mapping
Magnetic Resonance (MR) scanswere obtained using a Siemens (Er-
langen, Germany) 3T Tim TRIO Scanner atWashington UniversityMed-
ical School. T1-weighted imageswere acquired using a sagittal MPRAGE
3D sequence (TR = 2400 ms, TE = 3.16 ms, ﬂip = 8°; voxel size =
1 × 1 × 1 mm).
Surfaces of the hippocampus, amygdala, basal ganglia (i.e. caudate,
nucleus accumbens, putamen and globus pallidus), and thalamus
were automatically generated using FS + LDDMM, as previously de-
scribed (Khanet al., 2008). In brief, thismethod combines a probabilistic
voxel-based classiﬁcation method of FreeSurfer (Desikan et al., 2006)
and a deformable template-based method of large deformation
diffeomorphic metric mapping (LDDMM) (Beg et al., 2005). The initial
subcortical segmentations for the hippocampus, amygdala, basal gan-
glia and thalamuswere obtained fromFreeSurfer version 5.3.0, followed
by image registration with LDDMM that produced smooth transforma-
tions for each region of interest (ROI). A previously-published template
based on a healthy volunteer was used (Wang et al., 2008) to derive the
segmentations and surfaces. Subcortical segmentations for the hippo-
campus and thalamus also included boundaries demarcating constitu-
ent subﬁelds. Each ROI volume was calculated as the enclosed volume
of the mapped surface. Intracranial volume, total gray matter volume
and cortical white matter volume were obtained directly from the
FreeSurfer pipeline output.
2.4. Statistical analyses
Statistical analyses (excluding shape) were done using SAS 9.4 (SAS
Institute Inc., Cary, NC). Repeated measures ANCOVA (covaried for age
and sex) were used to investigate volumetric group differences in sub-
cortical brain regions, using hemisphere as the repeated measure. To
Table 1
Demographics table.
Characteristics Control SCZ Schizotypal PBP NPBP
(n = 40) (n = 52) (n = 12) (n = 49) (n = 24)
Age —Mean (SD) 24.9 (5.0) 26.1 (4.1) 22.4 (3.5) 25.2 (3.6) 26.2 (3.7)
Sex — N (%)
Female 20 (50.0) 14 (26.9) 5 (45.5) 29 (59.2) 16 (66.7)
Male 20 (50.0) 38 (73.1) 6 (54.5) 20 (40.8) 8 (33.3)
Race (%)
Asian 2 (5.0) 0 0 1 (2.0) 2 (8.3)
Black 21 (52.5) 27 (51.9) 3 (27.3) 13 (26.5) 2 (8.3)
Hispanic 0 0 0 3 (6.1) 0
White 17 (42.5) 25 (48.1) 8 (72.7) 30 (61.2) 18 (75.0)
Mixed/other 0 0 0 2 (4.1) 2 (8.3)
Handedness
Right 36 (90.0) 50 (96.2) 9 (81.8) 45 (91.8) 21 (87.5)
Left 4 (10.0) 2 (3.8) 2 (18.2) 4 (8.2) 3 (12.5)
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investigate volumetric effects relative to brain size, intracranial volume
was also included as a covariate in speciﬁc analyses. Relationships with
volumes were explored using Pearson correlations, partialling out diag-
nosis, age and sex.
To compare structural shape across groups, surface displacement
maps were ﬁrst generated by computing the surface-normal compo-
nent of the displacement of each surface vertex relative to the overall
average for every participant. Then, pairwise group differenceswere ex-
amined using SurfStat,(Chung et al., 2010;Worsley et al., 2009) compar-
ing each clinical group with CON. For each group pair, a linear mixed-
effectsmodelwas performed at each vertex,modeling the displacement
and using group, age and sex as the independent predictors. This pro-
duced a coefﬁcient estimate and pooled standard error for group, from
which a t-statistic was calculated. Signiﬁcance was corrected for multi-
ple comparisons by applying random ﬁeld theory (RFT),(Adler, 1981;
Adler and Hasofer, 1976) and visualized as a color map on the overall
average surface. RFT on surfaces was an extension of the body of work
by Worsley and colleagues on detecting functional MRI activation in
3-dimensional volumetric data (Worsley et al., 1999; Taylor and
Worsley, 2007). Multiple comparison correction methods such as
Bonferroni or false discovery rate (FDR)(Genovese et al., 2002) are not
appropriate because certain properties of the neuroimaging data are
not considered by these methods (Perneger, 1998). Namely, signals on
adjacent vertices are correlated; signals may be spatially continuous
(i.e., forming clusters) therefore the spatial extent of the signals must
be considered in addition to peaks. RFT considers both peaks and spatial
extent of the signal by modeling the noise as Gaussian random ﬁelds
(Worsley, 2005; Chumbley and Friston, 2009). The topology is de-
scribed by the expected Euler characteristic, which at high thresholds
of the unadjusted p-value, becomes the expected number of clusters
and approximates the family-wide error rate (FWER). On the surface,
the expected Euler characteristic is calculated in terms of a search
area, a roughness matrix and a given unadjusted p-value. The ﬁrst two
terms can be expressed together as counts of resel (resolution element),
where resel is deﬁned by the FWHM ﬁlter used to smooth the surface
data. Then for a givenunadjusted highly signiﬁcant p-value at the vertex
level, the Euler characteristic is the number of clusters, and the expected
Euler characteristic approximates the adjusted p-value at the cluster
level.
3. Results
3.1. Intracranial, gray matter and white matter volumes
Intracranial volumes showed a signiﬁcant group effect (F= 3.6; p=
0.008). Least squared (controlling for age and sex)means of intracranial
volumes were (in mm3): 1,518,123 for CON; 1,486,408 for SCZ;
1,525,578 for STP; 1,598,787 for P-BP; and 1,556,028 for N-BP. Post
hoc analyses showed signiﬁcant differences between SCZ and P-BP
(p = 0.0004).
Total gray matter volumes showed a signiﬁcant group effect (F =
3.9; p = 0.005). Least squared means of total gray matter volumes
were (in mm3): 653,545 for CON; 622,722 for SCZ; 649,297 for STP;
667,948 for P-BP; and 660,335 for N-BP. Post hoc analyses showed sig-
niﬁcant differences between CON and SCZ (p = 0.01); SCZ and P-BP
(p = 0.0002); and SCZ and N-BP (p = 0.01).
Total white matter volumes did not show a signiﬁcant group effect
(F = 1.8; p = 0.14).
3.2. Hippocampus volume and shape
Hippocampal and other subcortical volumes are shown in Table 2.
After controlling for age and sex, therewere no signiﬁcant group effects.
Including total intracranial volume as a covariate did not change non-
signiﬁcant group effects.
Hemispheric effects were signiﬁcant (p b 0.0001), but there was no
group by hemisphere effect. Left hippocampi were smaller than right
hippocampi. Shape analysis of the hippocampus resulted in signiﬁcant
group differences, as shown in Fig. 1A. Notable surface deformations
in the hippocampus and other subcortical structures, across groups,
are also displayed in Table 3.
3.3. Amygdala volume and shape
There were no signiﬁcant group differences in amygdala volumes.
No signiﬁcant group differences were present, with or without includ-
ing total intracranial volume as a covariate. There were also no
Table 2
Subcortical volumes.
Region Control SCZ Schizotypal PBP NPBP F p
(n =
40)
(n =
52)
(n = 12) (n =
49)
(n =
24)
Hippocampus
Left
Absolute 2418 2330 2417 2512 2443 2.2 0.07
Relative 2441 2396 2431 2431 2421 0.1 0.98
Right
Absolute 2799 2742 2794 2903 2869
Relative 2827 2820 2811 2807 2843
Amygdala
Left
Absolute 1350 1315 1326 1386 1340 1.7 0.16
Relative 1364 1354 1334 1338 1327 0.4 0.81
Right
Absolute 1392 1352 1376 1439 1391
Relative 1405 1390 1385 1392 1377
Caudate
Left
Absolute 3549 3581 3399 3595 3432 1.0 0.43
Relative 3588 3690 3422 3460 3396 4.6 0.001*
Right
Absolute 3516 3555 3416 3584 3409
Relative 3553 3660 3439 3454 3373
Nucleus accumbens
Left
Absolute 376 379 388 383 373 0.4 0.84
Relative 380 388 390 371 370 1.2 0.31
Right
Absolute 370 366 373 378 369
Relative 373 375 375 366 366
Putamen
Left
Absolute 4767 4899 4868 4927 4692 1.2 0.33
Relative 4811 5022 4894 4775 4651 3.6 0.008*
Right
Absolute 5074 5192 5137 5258 5020
Relative 5119 5320 5165 5100 4977
Globus pallidus
Left
Absolute 1648 1683 1615 1698 1589 1.9 0.11
Relative 1663 1726 1624 1646 1575 4.9 0.0009*
Right
Absolute 1652 1687 1631 1711 1608
Relative 1666 1728 1640 1661 1594
Thalamus
Left
Absolute 7681 7495 7617 7751 7599 0.9 0.49
Relative 7749 7689 7658 7512 7533 1.9 0.12
Right
Absolute 7353 7225 7289 7438 7237
Relative 7412 7392 7325 7232 7181
Reported volumes are in mm3.
All volumes and results were controlled for age and sex.
Results were derived from repeated measures ANOVA using hemisphere as a repeated
measure.
⁎ p b 0.01.
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Fig. 1. Shape analysis of individual subcortical structures. The ﬁgures depict displacement maps, generated from mean surfaces of the indicated diagnostic groups relative to healthy
controls, for the: hippocampus (A), amygdala (B), caudate (C), nucleus accumbens (D), putamen (E), globus pallidus (F), and thalamus (G). Results were corrected for age and sex.
Demarcation lines on hippocampal and thalamic surfaces separate designated subﬁelds or nuclei, and are indicated on the ﬁrst listed comparisons. Hippocampal subﬁelds: CA1,
subiculum (SUB), and the remaining regions which include CA2, CA3, CA4 and the dentate gyrus (REM). Thalamic nuclei: anterior nucleus (ANT), medial dorsal nucleus (MD),
pulvinar (PUL), and the remaining nuclei (REM), which include the lateral dorsal, lateral posterior, ventral anterior, ventral lateral, ventral intermedial, and ventral posterior nuclei, as
well as the medial and lateral geniculate bodies. Regions in green did not show signiﬁcant group differences after RFT multiple comparison correction. T-values with cooler colors
(t b 0) indicate inward surface deformity, and warmer colors (t N 0) indicate outward surface deformity. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the web version of this article.)
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signiﬁcant hemispheric effects for amygdala volume. Fig. 1B shows
shape ﬁndings for the amygdala.
3.4. Caudate volume and shape
There were no signiﬁcant group effects for caudate volume; and
there were no signiﬁcant hemispheric effects. Shape ﬁndings involving
the caudate are shown in Fig. 1C. Including total intracranial volume
as a covariate resulted in a signiﬁcant group effect for caudate volume
(p = 0.001). Post hoc analyses showed the following signiﬁcant group
effects for caudate volume on the left: CON N N-BP (p = 0.018);
SCZ N SPE (p = 0.012); SCZ N P-BP (p = 0.0007); and SCZ N N-BP
(p = 0.0003). Signiﬁcant volume effects on the right were: CON N N-
BP (p = 0.029); SCZ N SPE (p = 0.04); SCZ N P-BP (p = 0.003); and
SCZ N N-BP (p = 0.0005). By correcting shape ﬁndings for intracranial
size, we explored the regions of the caudate contributing to the de-
scribed volumetric group differences. As seen in Fig. 2A, the increase
in caudate volume in SCZ is localized to the most anterior region of
the head.
3.5. Nucleus accumbens volume and shape
There were no signiﬁcant group effects for nucleus accumbens vol-
ume (with or without intracranial volume correction). There were no
signiﬁcant hemispheric effects for volume. Fig. 1D shows shape ﬁndings
for the nucleus accumbens.
3.6. Putamen volume and shape
There were no signiﬁcant group effects for putamen volume. There
were however signiﬁcant hemispheric effects (p b 0.0001), but no
group by hemisphere effects. Putamina were smaller on the left than
on the right. Shape ﬁndings for the putamen are shown in in Fig. 1E. In-
cluding total intracranial volume as a covariate resulted in a signiﬁcant
group effect for putamen volume (p = 0.006). Post hoc analyses
showed the following signiﬁcant group effects for volume on the left:
CON b SCZ (p = 0.01); SCZ N P-BP (p = 0.004); and SCZ N N-BP (p =
0.0003). Signiﬁcant effects for putamen volume on the right were:
CON b SCZ (p = 0.03); SCZ N P-BP (p = 0.02); and SCZ N N-BP (p =
0.002). In SCZ, after correcting for intracranial volumes, surface
Fig. 1 (continued).
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expansion was observed in the posterior dorsal putamen, and laterally
on the right (Fig. 2A). No surface expansion was seen in the other
groups (Fig. 2B–D).
3.7. Globus pallidus volume and shape
There were no signiﬁcant group effects or hemispheric effects for
globus pallidus volume. Shape ﬁndings are shown in Fig.1F. Including
total intracranial volume as a covariate resulted in a signiﬁcant group ef-
fect for volume (p = 0.0007). Post hoc analyses showed the following
signiﬁcant group volume effects on the left: CON b SCZ (p = 0.02);
CON N N-BP (p = 0.009); SCZ N SPE (p = 0.02); SCZ N P-BP (p =
0.004); SCZ NN-BP (pb 0.0001); and P-BP NN-BP (p=0.03). Signiﬁcant
volume effects on the right were: CON b SCZ (p = 0.03); CON N N-BP
(p = 0.04); SCZ N P-BP (p = 0.02); and SCZ N N-BP (p = 0.0002).
Fig. 2A shows surface deformation in SCZ after correcting for intracrani-
al volumes. Regions of surface expansion were present dorsally along
the ventrolateral edges.
3.8. Thalamus volume and shape
There were no signiﬁcant group volume effects, and correcting for
intracranial volumes did not change overall results. There were also
no signiﬁcant hemispheric effects for volume. Shape ﬁndings involving
the thalamus are shown in Fig. 1G.
3.9. Clinical correlations
Correlation results are shown in Table 4. Total gray matter volume
inversely correlated with total SANS (r = −0.25; p = 0.0009) and
SAPS positive symptoms (r=−0.2; p= 0.008), but not with SAPS dis-
organization symptoms. Cortical white matter volume showed a signif-
icant inverse relationshipwith the SANS (r=−0.16; p=0.03), but not
with SAPS domains. Among the subcortical structures, signiﬁcant clini-
cal relationships were only found for the hippocampus, amygdala and
thalamus. The left hippocampus only correlated with SAPS disorganiza-
tion (r =−0.19; p = 0.01) and SANS (r =−0.21; p = 0.006). There
were no signiﬁcant correlations for the right hippocampus. Both left
and right amygdala volumes were signiﬁcantly related to SANS scores
(left: r = −0.17, p = 0.02; right: r = −0.19, p = 0.01). Similarly,
both left and right thalamus volumes were signiﬁcantly related to
SANS scores (left: r =−0.16, p = 0.03; right: r =−0.15, p = 0.049).
In those subcortical structures with group volume differences, ver-
tex deformationwas also investigated relative to clinical domain scores,
excluding diagnosis, age and sex effects (Fig. 3). Hippocampal contrac-
tion with disorganization and negative symptoms was localized mainly
to the lateral CA1 region. Additionally, negative symptoms were related
to medial subiculum contraction. Positive symptoms, on the other hand
were associated with anterior CA1 contraction (Fig. 3A). Reduced vol-
umes of the amygdala with negative symptoms involved diffuse surface
regions, most notably on the right posterior surface (Fig. 3B). Thalamus
volume contractionwith negative symptomswas localized to the lateral
thalamic surface; while that with positive symptoms was mainly local-
ized to the anterior and posterior extremes.
4. Discussion
Shape analysis complements volumetric analysis, and can identify
subtle regional abnormalities on brain structures helping to localize
speciﬁc pathophysiologic pathways. Our study compared the volumes
and shapes of multiple subcortical brain structures in healthy and psy-
chiatric populations. We did not ﬁnd absolute volumetric group differ-
ences for any of the subcortical structures studied, but some structures
showed differences after controlling for brain size. Shape analysis on
the other hand showed regional surface deformations in each diagnostic
group. Contrary to our expectation, we only found little overlap in the
pattern of deformation across groups.
4.1. Hippocampus
In our study, hippocampal shape analyses revealed regional group
differences despite similar volumes across groups. In SCZ, the hippo-
campuswasmost deformed on the right sidewith shrinkage in the ven-
tral subiculum. The subiculum receives input from CA1 and entorhinal
cortical layer III pyramidal neurons and is themain output of the hippo-
campus (Small et al., 2011). Given the widespread set of cortical and
subcortical areas with which it interacts, it is able to inﬂuence activity
in disparate brain regions (Small et al., 2011; O'Mara, 2005). Although
the exact roles of the subiculum are unclear, it has been suggested
that there is a segregation of function within the subiculum: the dorsal
component mainly being involved in processing of spatial, movement
and memory information; and the ventral component playing a major
role in the inhibition of the HPA axis stress response (O'Mara, 2005).
Smaller hippocampi is often seen in studies of SCZ patients,(Shepherd
et al., 2012; Adriano et al., 2012) as well as smaller subiculum volumes
(Haukvik et al., 2015). Results regarding the location of hippocampal
shrinkage however have varied across studies, having been reported
in the head or anterior region(Csernansky et al., 2002; Mamah et al.,
2012; Johnson et al., 2013; Qiu et al., 2010; Zierhut et al., 2013) and
the body or tail (Liberg et al., 2014; Liberg et al., 2015). Furthermore,
CA1 regional deformation has been described in SCZ (Csernansky
et al., 2002; Small et al., 2011). We found that in STP participants, the
hippocampuswas less deformed than in SCZ, without any notable over-
lapping regions. However, similar to SCZ, the STP group had hippocam-
pal deformations in the subiculum, which thus may indicate a role of
this region in schizophrenia spectrum disorder neurobiology. In the P-
BP participants, hippocampal shrinkage involved regions outside of
the subiculum and CA1; however N-BP participants had normal hippo-
campi suggesting that psychosis status in BP may be associated with
Table 3
Notable subcortical shape ﬁndings.
Surface Deformation SCZ STP PBP NPBP
L R L R L R L R
Hippocampus
Subiculum contraction − ++ − + − − − −
CA2–4 + dentate contraction − − − − ++ ++ − −
CA1 contraction + − − − − − − −
CA1 expansion − − − + ++ ++ − −
Amygdala
Posteriolateral contraction − + − − − − − −
Posteriomedial contraction − − − − − − + ++
Caudate
Ventral contraction + − + − + + − −
Dorsal contraction − − − − − − ++ ++
Nucleus Accumbens
Ventral contraction − − − − + + − +
Dorsolateral expansion − − − − + − − −
Putamen
Posteromedial contraction − − − − − − + +
Posterolateral expansion − − − − − − + −
Mediolateral expansion − − − − + + − −
Medial expansion − − − − − − + +
Posterosuperior expansion − − − − + + − −
Globus pallidus
Anterosuperior contraction − − − − − − − +
Inferior contraction − − − − − − + +
Superiomedial expansion + + − − ++ ++ − −
Lateral expansion + − − − + + − −
Thalamus
Anterior contraction + − − − − − ++ ++
Pulvinar contraction + − − − − + ++ ++
Superior contraction + − − − − − ++ ++
Surface deformation estimates are derived from comparisons of mean groups to mean
control subjects, and controlled for age and sex.
+: mild or moderate surface deformation.
++: large surface deformation.
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hippocampal deformation. Smaller hippocampi are seen less commonly
in BP than in SCZ (Otten andMeeter, 2015; van Erp et al., 2012). Shrink-
age of the head and medial border of the left hippocampus has been re-
ported in BP, along with expansion on the right hippocampal tail
medially (Quigley et al., 2015). Our study results also showed a relation-
ship between clinical symptoms and smaller hippocampal volumes on
the left side. While our study did not show signiﬁcant volumetric
group effects, there was a trend level effect for left hippocampal volume
in SCZ. This is consistent with some studies that have found a reduction
in hippocampal size selectively on the left side (Kawano et al., 2015;
Stefanis et al., 1999). Smaller left hippocampus has also been found to
be a risk indicator for psychosis (Seidman et al., 2002) andmay indicate
a preferential vulnerability of the left hippocampus to environmental
stress (Stefanis et al., 1999; Mohanakrishnan Menon et al., 2003; Shu
et al., 2013).
4.2. Amygdala
Few studies have evaluated amygdala shape in psychiatric disorders.
Surface deﬂation of the left amygdala has been reported in ﬁrst episode
mania and bilaterally in ﬁrst episode SCZ (Qiu et al., 2013). Others found
bilateral shrinkage of the basolateral, basomedial and centromedial
amygdala and the left lateral subregion in SCZ compared to P-
BP(Mahon et al., 2015). Negative ﬁndings have also been reported in
SCZ (Shenton et al., 2002). In our study, we found that the amygdala
in SCZ has several shrunken regions, principally those corresponding
to lateral and centromedial subﬁelds. Both BP subgroups showed
more extensive shrinkage than SCZ. Regional deformation may be rele-
vant to abnormal emotional processing, particularly in BP patients. Sen-
sory inputs to the amygdala (e.g. from the hippocampus, primary
auditory cortex, processed visual information from temporal cortex)
terminate in the lateral nucleus. The structural organization and cellular
composition of the lateral portions of the amygdala are cortex-like, and
the majority of neurons are glutamatergic projection neurons. In con-
trast, the medial structures are striatum-like, and consist of GABAergic
neurons (Lee et al., 2013; Ehrlich et al., 2009). Our ﬁndings therefore
suggest structural abnormalities involving both excitatory and inhibito-
ry neurons of the amygdala in SCZ and BP.
4.3. Thalamus
In the SCZ thalamus,we observed surface contraction in the pulvinar
and ventral lateral nucleus. The pulvinar is a collection of nuclei with
widespread connections to areas that include visual cortex, posterior
parietal cortex, cingulate, premotor, prefrontal and the superior
colliculi,(Grieve et al., 2000) and is involved in visual attention including
linking visual stimuli with context-speciﬁc motor responses (Grieve
et al., 2000; Arend et al., 2008). In addition to visual salience, the
pulvinar also has been implicated in social cognition, including face pro-
cessing (Benarroch, 2015; Nguyen et al., 2013; Saalmann and Kastner,
2013). The ventral lateral nucleus targets efferents including the
motor cortex, premotor cortex and supplementary motor cortex, facili-
tating the coordination and planning of movement. Previous shape
studies in SCZ have found decreased sizes of various nuclei including
the pulvinar, and the ventral lateral, anterior and mediodorsal nuclei
(Csernansky et al., 2004; Smith et al., 2011; Danivas et al., 2013). In
the current study, the BP participants also showed posterior thalamic
shrinkage. However, BP participants also had shrinkage in regions of
the anterior and dorsal lateral nuclei. Connectionally and structurally,
the lateral dorsal nuclei are reportedly similar to that of the anterior nu-
clei, and play a role in spatial memory and learning (van Groen et al.,
2002). The clinical relevance of the observed shape abnormalities is
Fig. 2. Shape analysis after brain size correction. The ﬁgures depict displacement maps for the basal ganglia (i.e. caudate, nucleus accumbens, putamen, and globus pallidus) and thalamus,
presented together as they appear naturally. Maps were generated frommean surfaces of the indicated diagnostic groups relative to healthy controls. Results were corrected for age, sex and
intracranial volume. Regions in green did not show signiﬁcant group differences after RFT multiple comparison correction. T-values with cooler colors (t b 0) indicate inward surface
deformity, and warmer colors (t N 0) indicate outward surface deformity. A = anterior; P = posterior; L = left; R = right.
282 D. Mamah et al. / NeuroImage: Clinical 11 (2016) 276–286
suggested by results of our correlational analyses, which showed that
psychotic symptoms were localized to anterior and posterior thalamic
nuclei.
4.4. Basal ganglia
Brain size corrected analyses resulted in signiﬁcant group volume ef-
fects in the basal ganglia, driven primarily by enlargement in SCZ. Basal
ganglia enlargement was localized to speciﬁc surface regions (across all
nuclei), generally with some symmetry. The signiﬁcance of the affected
regions is unclear, and do not correlate with the distribution dopami-
nergic receptor subtypes (Rosa-Neto et al., 2004). Considering the well
documented medication effects on basal ganglia structures(Mamah
et al., 2007; Breier et al., 1992; McCarley et al., 1999; Staal et al., 2000;
van Erp et al., 2016), it is probable that basal ganglia enlargement in
our study is a consequence of past use of typical antipsychotic drugs
(such as haloperidol or ﬂuphenazine), which are predominantly antag-
onists of the D2-subtype dopaminergic receptor. These receptors are
highly abundant in the striatum, which have substantial dopaminergic
afferents from the substantia nigra and the ventral tegmental area
(Rosa-Neto et al., 2004; Hall et al., 1994). In animal studies, D2-
receptor blockade has been shown to cause striatal enlargement inmul-
tiple studies (Chakos et al., 1998; Andersson et al., 2002; Vernon et al.,
2012). Most other investigators have also observed volume enlarge-
ment of basal ganglia nuclei in SCZ patients (Mamah et al., 2007;
Breier et al., 1992; McCarley et al., 1999; Staal et al., 2000; van Erp
et al., 2016). A positive correlation between typical antipsychotic dose
and striatal volume has been observed, supporting a trophic effect
(Chakos et al., 1994; DeLisi et al., 1991; Doraiswamy et al., 1995; Gur
et al., 1998; Shihabuddin et al., 1998; Swayze et al., 1992). In contrast
to volume increases with typical antipsychotics, normal (Gunduz
et al., 2002) and decreased (Corson et al., 1999; Keshavan et al., 1998)
basal ganglia volumes are generally reported in neuroleptic-naïve
patients or those on newer generation antipsychotic drugs. Also, an ab-
sence of basal ganglia enlargement in unaffected schizophrenia relatives
is typical (Mamah et al., 2008; Staal et al., 2000) although some authors
have found increased basal ganglia size in relatives (Oertel-Knochel
et al., 2012). Several mechanisms underlying basal ganglia volume in-
crease following D2-receptor blockade have been proposed. Disruption
of the normal homeostatic mechanisms of target neurons in the basal
ganglia appears to occur leading to a number of compensatory changes,
manifesting as hypertrophy macroscopically (Andersson et al., 2002;
Konradi and Heckers, 2001). Chronic haloperidol use has been associat-
ed with increased synaptic density in the striatum,(Meshul and Casey,
1989; Meshul et al., 1994; Eastwood et al., 1997) mainly of the gluta-
matergic type(Meshul and Casey, 1989; Kerns et al., 1992; See et al.,
1992; Uranova et al., 1991) and possibly associated with increased
synaptophysin expression(Eastwood et al., 1997). Others have found in-
creased neuronal size, particularly in axon terminals in the
striatum,(Kerns et al., 1992; Uranova et al., 1991; Benes et al., 1985)
or an increase in the number of striatal neurons (Beckmann and Lauer,
1997; Lauer and Beckmann, 1997). Complicating the understanding of
antipsychotic trophic effects is that long-term treatment or high dosing
can also induce neurotoxicity and loss of brain volume (Andreassen and
Jorgensen, 2000; Burkhardt et al., 1993; Goff et al., 1995; Altunkaynak
et al., 2012). Therefore, dependent on drug concentration, treatment
time and individual sensitivity, the neurotrophic or neurotoxic proper-
ties appear to determine basal ganglia volume increase or decrease re-
spectively (Konradi and Heckers, 2001). By contrast to SCZ, both BP
subgroups hadmultiple deﬂated regions, presumably since typical anti-
psychotics are infrequently used in these populations. This is particular-
ly true for N-BP patients, who had the most extensive basal ganglia
deﬂation. Basal ganglia surface deﬂation has been previously reported
in BP, with variable ﬁndings: in the anterior and ventral
striatum,(Hwang et al., 2006) dorsal caudate,(Womer et al., 2014) left
ventromedial caudate(Ong et al., 2012) and right putamen (Liberg
et al., 2014). Others found no surface abnormality in BP, but a relation-
ship of striatal deﬂation to illness severity (Liberg et al., 2015).
4.5. Conclusions & limitations
In summary, our study found group differences in surface shapes of
several subcortical brain structures, despite an absence of volumetric ef-
fects. Surface deformation patterns in individual diagnostic groupswere
largely unique; however related deformities were seen in the posterior
thalamus in SCZ, P-BP and N-BP, as well as in the hippocampal
subiculum in SCZ and STP. Basal ganglia surface enlargements in SCZ
suggested typical antipsychotic drug effects. The results of our studies
suggest distinct neurobiological abnormalities in each disorder, with
minimal overlap across disorders. Findings however can be confounded
by factors, which can limit the conclusion drawn from our study. Medi-
cations and recreational drugs could also inﬂuence brain structure
(other than the basal ganglia), which are difﬁcult to correct. For exam-
ple, the typical antipsychotic drug, haloperidol has been reported to de-
crease cortical gray matter and whole brain volume,(Vernon et al.,
2012) as well as subcortical structures such as the hippocampus
(Mamah et al., 2012). Lithium and antidepressant drugs have also
been reported to increase cortical gray matter (Otten and Meeter,
2015; Vernon et al., 2012; Hajek et al., 2014; Connor et al., 2004;
Hartberg et al., 2015). However, studies showing similar regional defor-
mations in nonpsychotic and unmedicated siblings of patients suggest
that surface structural abnormalities can be fairlywell estimated despite
potential drug effects (Mamah et al., 2008; Harms et al., 2007; Tepest
et al., 2003). The FS + LDDMM shape methodology, while robust, may
also be less accurate in delineating smaller structures(Khan et al.,
2008). Thus, results may have underestimated shape abnormalities in
the smaller nucleus accumbens or amygdala. Future studies involving
more extensive behavioral measures, including cognition, would also
be beneﬁcial in further clarifying the clinical relationships of regional
Table 4
Clinical correlations.
Region Positive
symptomsa
Disorg.
symptomsb
Negative
symptomsc
pa pb pc
Total gray
matter
−0.20 −0.13 −0.25 0.008⁎ 0.08 −0.0009⁎
Cortical white
matter
−0.09 −0.05 −0.16 0.24 0.37 0.03⁎
Hippocampus
Left −0.14 −0.19 −0.21 0.06 0.01 0.006
Right −0.10 −0.12 0.14 0.17 0.12 0.06
Amygdala
Left −0.08 −0.13 −0.17 0.28 0.09 0.02⁎
Right −0.09 −0.13 −0.19 0.21 0.08 0.01⁎
Caudate
Left −0.05 −0.11 −0.09 0.49 0.15 0.24
Right −0.07 −0.13 −0.08 0.39 0.09 0.28
Nucleus
accumbens
Left −0.13 −0.02 −0.06 0.09 0.75 0.42
Right −0.14 −0.02 −0.09 0.07 0.77 0.26
Putamen
Left −0.06 −0.06 −0.02 0.45 0.43 0.81
Right −0.08 −0.06 −0.03 0.32 0.33 0.67
Globus
pallidus
Left 0.00 −0.02 −0.05 0.99 0.83 0.51
Right −0.03 −0.01 −0.04 0.67 0.82 0.63
Thalamus
Left −0.15 −0.07 −0.16 0.04⁎ 0.36 0.03⁎
Right −0.14 −0.05 −0.15 0.07 0.55 0.05⁎
Relationships were analyzed using Pearson correlations partially controlled for diagnosis,
age and sex.
a relates to positive symptoms (derived from SAPS) Pearson's r or p values.
b relates to disorganized symptoms (derived from SAPS) Pearson's r or p values.
c relates to negative symptoms (derived from SANS) Pearson's r or p values.
⁎ p b 0.05.
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surface deformations. Developments in morphometric methods may
allow more precise early identiﬁcation of psychiatric disorders and
risk states, and aid the monitoring of treatment effects.
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